A recent study has shown that OE prevents doxorubicin-induced cardiomyopathy through the modulation of kinases such as Akt [20], a serine/threonine-specific protein kinase that plays a key role in apoptosis and cell proliferation [36]. Here, DYRK1A is linked to cardiomyopathy.